Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_assertion type Assertion NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_head.
- NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_assertion description "[Experimental Design The mRNA levels of TSC22D1 and PSAP were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) in 223 estrogen receptor-positive primary breast tumors of patients with recurrent disease treated with first-line tamoxifen therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_provenance.
- NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_assertion evidence source_evidence_literature NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_provenance.
- NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_assertion SIO_000772 18299979 NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_provenance.
- NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_assertion wasDerivedFrom befree-2016 NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_provenance.
- NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_assertion wasGeneratedBy ECO_0000203 NP657391.RAUGQ8iwfYOsS8AsMI_d9rXSXioCv-SydEdXmGgbrnQY8130_provenance.